Back to VA VANGUARD CAPITAL MANAGEMENT LLC
LPCN2 quarters
Position history for VAVANGUARD CAPITAL MANAGEMENT LLC's holdings in LIPOCINE INC NEW
Yes. Vanguard Capital Management holds 230,823 shares of LPCN (Lipocine), worth $590,907, as of its Q2 2026 13F filing. It increased the position by 30,155 shares (+15.0%) from Q1 2026. Vanguard Capital Management has held LPCN in every 13F on record since Q1 2026, 2 quarterly filings.
Current Value
$590,907
Current Shares
230,823
Total Value Change
-$1M
Total Shares Change
+30,155
Quarter-by-Quarter History
Other major holders of LPCN: VANGUARD GROUP INC, BlackRock Finance, Inc.